Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis

Journal of Infectious Diseases

Volumn 169, Issue 3, 1994, Pages 512-518

  Jennings, A D ^a,b,c   Gibson, C A ^a,b,c,d   Miller, B R ^a,b,c   Mathews, J H ^a,b,c   Mitchell, C J ^a,b,c   Roehrig, J T ^a,b,c   Wood, D J ^a,b,c   Taffs, F ^a,b,c   Sil, B K ^a,b,c,e   Whitby, S N ^a,b,c,f   Whitby, J E ^a,b,c,g   Monath, T P ^a,b,c,h   Minor, P D ^a,b,c   Sanders, P G ^a,b,c   Barrett, A D T ^a,b,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d Veterinary Research Institute ^*  (Australia)

^e BANGLADESH LIVESTOCK RESEARCH INSTITUTE   (Bangladesh)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g VETERINARY LABORATORIES AGENCY   (United Kingdom)

^h Acambis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; VIRUS PROTEIN; VIRUS VACCINE;

AEDES AEGYPTI; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HUMAN; HUMAN CELL; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENCEPHALITIS; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS VIRULENCE; YELLOW FEVER FLAVIVIRUS;

AEDES; AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BASE SEQUENCE; DNA, VIRAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; HUMAN; MACACA FASCICULARIS; MICE; MOLECULAR SEQUENCE DATA; NASAL MUCOSA; SUPPORT, NON-U.S. GOV'T; TEMPERATURE; TUMOR CELLS, CULTURED; VERO CELLS; VIRAL VACCINES; VIRULENCE; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 0027955181     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.3.512     Document Type: Article

References (31)

1. Monath TP. Flaviviruses. In: Fields BN. Knipe DM. Charnock RM. et al. Fields Virology. 2nd ed. New York: Raven Press, 1990:9841004.
2. Anonymous Fatal viral encephalitis following 17D yellow fever vaccine inoculation. JAMA 1966;198:671-2.
3. Schoub BD. Dommann CJ, Johnson S, Downie C, Patel PL. Encephalitis in a 13-year-old boy following 17D yellow fever vaccine. J Infect 1990;21:105-6.
4. Merlo C. Steffen R. Landis T, Tsai T, Karabatsos N. Possible association of encephalitis and 17D yellow fever vaccination in a 29-year-old traveller [letter]. Vaccine 1993:11:691.
5. Theiler M, Smith HH. Effect of prolonged cultivation in vitro upon pathogenicity of yellow fever virus. J Exp Med 1937:65:767-86.
6. Mathis E. Sellards AS. Laigret S. Sensibilite du Maccus rhesus au virus de fievre jaune. Compte rendu hebdomaclaire des seances de l'Aca-demie des Sciences. 1928;186:604-6.
7. Miller BR, Monath TP, Tabachinick WJ, Ezike VI. Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol 1989;40:396-9.
8. Okello GBA, Agata N., Ouma J, et al. Outbreak of yellow fever in Kenya [letter]. Lancet 1993:341:489.
9. Barrett ADT. Yellow fever vaccines. Bull Inst Pasteur 1987:85:103-24.
10. Barrett ADT. Gould EA. Comparison of neurovirulence of different strains of yellow fever virus in mice. J Gen Virol 1986;67:631-7.
11. Barrett ADT, Pryde A, Median AR, et al. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies. Vaccine 1989;7:333-6.
12. Ledger TN, Sil BK, Wills MR, et al. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies. Biologicals 1992:20:117-28.
13. Sil BK, Dunster LM, Ledger TN, Wills MR, Minor PD, Barrett ADT. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus. J Virol 1992;66:4265-70.
14. Gentry MK, Henchal EA, Mc Cown JM, Brandt WE, Dalrymple JM. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg 1982:31:54855.
15. Henchal EA, Mc Cown JM, Burke DS, Seguin MC, Brandt WE. Epito-pic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg 1985;34:162-9.
16. Roehrig JT, Mathews JH, Trent DW. Identification of epitopes on the E-glycoprotein of St. Louis encephalitis virus using monoclonal antibodies. Virology 1983:128:118-26.
17. World Health Organization. Requirements for yellow fever vaccine (revised 1975). Geneva: WHO, technical report series 1976;(no. 594):23-49.
18. World Health Organization Requirements for poliomyelitis vaccine (oral) (revised 1989). Geneva: WHO, technical report series 1990;(no. 800):30-86.
19. Whitby JE, Jennings AD, Barrett ADT. Improved reverse transcription and amplification of flaviviral RNA following low level methyl mercury hydroxide denaturation. Methods Mol Cell Biol 1992;3:193-7.
20. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution. Science 1985;229:726-33.
21. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
22. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977:74:5463-76.
23. Barrett ADT, Mathews JH, Miller BR, Median AR, Ledger TN, Roehrig JT. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus. J Gen Virol 1990;71:13-8.
24. Jennings AD, Whitby JE, Minor PD, Barrett ADT. Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses. Vaccine 1993:11:679-81.
25. Ballinger-Crabtree ME, Miller BR. Partial nucleotide sequence of South American yellow fever virus strain 1899/81 structural proteins and NS1. J Gen Virol 1990;71:2115-21.
26. Jennings AD, Whitby JE, Minor PD, Barrett ADT. Nucleotide and deduced amino acid sequence of the envelope protein of the wildtype French viscerotropic strain of yellow fever virus, and the French neurotropic vaccine strain derived from it. Virology 1993; 192:692-5.
27. Hahn CS, Dalrymple JM, Strauss JH, Rice CM. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc Natl Acad Sci USA 1987;84:2019-23.
28. Barrett ADT, Dunster LM, Ledger TN, et al. Evidence that the envelope protein of flaviviruses encodes determinants of attenuation and virulence. In: Brown F, Chanock RM, Ginsberg HS, Lerner RA, eds. Vaccines 90. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1990:101-4.
29. Miller BR, Mitchell CJ. Passage ofyellow fever virus: Its effect on infection and transmission rates in Aedes aegypli mosquitoes. Am J Trop Med Hyg 1986;35:1302-9.
30. Dupuy A, Despres P, Cahour A. Girard M, Bouloy M. Nucleotide sequence comparison of the genomes of two 17D-204 yellow fever vaccines. Nucleic Acids Res 1989:17:3989.
31. Liprandi F. Isolation of plaque variants differing in virulence from the 17D strain of yellow fever. J Gen Virol 1981;186:604-6.